GHDx
Published on GHDx (https://ghdx.healthdata.org)


Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma

General Info

Geography 
China (CHN)
Shaanxi
Coverage type 
Subnational
Time period covered 
January, 2011 - December, 2013
Data type
Scientific literature
Keywords 
Cirrhosis of the liver

Citation

Authors 
Ying X, Zhao Y, Wang JL, Zhou X, Zhao J, He CC, Guo XJ, Jin GH, Wang LJ, Zhu Q, Han SX
Journal 
Oncol Rep
Pages 
1550-6
Publication year 
2014
Suggested citation 
Ying X, Zhao Y, Wang JL, Zhou X, Zhao J, He CC, Guo XJ, Jin GH, Wang LJ, Zhu Q, Han SX. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma. Oncol Rep. 2014; 32(4): 1550-6.

Source URL:https://ghdx.healthdata.org/record/serum-anti-osteopontin-autoantibody-novel-diagnostic-and-prognostic-biomarker-patients#comment-0